Jubilant Life Sciences


Jubilant Life Sciences Jubilant Life Sciences Jubilant Life Sciences Jubilant Life Sciences Jubilant Life Sciences Jubilant Life Sciences Jubilant Life Sciences Jubilant Life Sciences Jubilant Life Sciences Jubilant Life Sciences Jubilant Life Sciences Jubilant Life Sciences Jubilant Life Sciences Jubilant Life Sciences Jubilant Life Sciences Jubilant Life Sciences

Jubilant Life Sciences

You are here : Home > Businesses > Life Science Products > Generics > Solid Dosage Forms > Markets

To know more on our US Operations:
Please visit: www.cadista.com

To know more on our EU Operations:
Please visit: www.jubilant.be

Business growth units have been established to tap key select “Pharmerging” markets of interest in:
  • SAARC – Headquartered in Corporate Office; Targeting Rural India and superspecialists.
  • ASIAPAC – Headquartered in Philippines; Targeting Philippines, Taiwan, Malaysia, Singapore and Japan;
  • LATAFME – Headquartered in Corporate Office; Targeting Brazil, Algeria and GCC and S. Africa
Business model selected for “Pharmerging markets” is “Licensing and Supply Agreement” or Distribution Agreement” with the large local pharma players/ distributors in these local markets.

© Copyright Jubilant Life Sciences. All rights reserved.